Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AdaptHealth (AHCO) Other Accumulated Expenses (2018 - 2026)

AdaptHealth has reported Other Accumulated Expenses over the past 8 years, most recently at $30.1 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 13.59% year-over-year to $30.1 million; the TTM value through Dec 2025 reached $30.1 million, up 13.59%, while the annual FY2025 figure was $30.1 million, 13.59% up from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $30.1 million at AdaptHealth, up from $29.0 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $108.3 million in Q1 2021 and troughed at $10.7 million in Q4 2023.
  • A 5-year average of $34.9 million and a median of $27.9 million in 2022 define the central range for Other Accumulated Expenses.
  • Biggest five-year swings in Other Accumulated Expenses: surged 557.86% in 2021 and later crashed 65.27% in 2022.
  • Year by year, Other Accumulated Expenses stood at $43.2 million in 2021, then tumbled by 54.01% to $19.9 million in 2022, then tumbled by 46.36% to $10.7 million in 2023, then soared by 148.78% to $26.5 million in 2024, then rose by 13.59% to $30.1 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for AHCO at $30.1 million in Q4 2025, $29.0 million in Q3 2025, and $28.9 million in Q2 2025.